Long V. Ly

993 total citations
19 papers, 753 citations indexed

About

Long V. Ly is a scholar working on Ophthalmology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Long V. Ly has authored 19 papers receiving a total of 753 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Ophthalmology, 10 papers in Immunology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Long V. Ly's work include Ocular Oncology and Treatments (10 papers), Immunotherapy and Immune Responses (9 papers) and Corneal Surgery and Treatments (6 papers). Long V. Ly is often cited by papers focused on Ocular Oncology and Treatments (10 papers), Immunotherapy and Immune Responses (9 papers) and Corneal Surgery and Treatments (6 papers). Long V. Ly collaborates with scholars based in Netherlands, United States and Australia. Long V. Ly's co-authors include Martine J. Jager, Ekaterina S. Jordanova, Mieke Versluis, Gregorius P. M. Luyten, J. Vrolijk, Inge H. G. Bronkhorst, Willem Maat, D. de Wolff–Rouendaal, Pieter A. van der Velden and Nicoline E. Schalij‐Delfos and has published in prestigious journals such as The Journal of Immunology, Cancer Research and Oncogene.

In The Last Decade

Long V. Ly

18 papers receiving 741 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Long V. Ly Netherlands 14 498 393 250 244 114 19 753
Inge H. G. Bronkhorst Netherlands 13 661 1.3× 438 1.1× 244 1.0× 262 1.1× 119 1.0× 17 838
Mieke Versluis Netherlands 16 567 1.1× 450 1.1× 273 1.1× 323 1.3× 133 1.2× 27 898
Willem Maat Netherlands 14 474 1.0× 186 0.5× 179 0.7× 275 1.1× 117 1.0× 15 620
Junna Oba Japan 12 233 0.5× 189 0.5× 227 0.9× 278 1.1× 45 0.4× 24 640
Mallikarjuna Kandalam India 16 241 0.5× 119 0.3× 236 0.9× 342 1.4× 37 0.3× 27 592
Sebastian Di Cesare Canada 11 237 0.5× 104 0.3× 112 0.4× 205 0.8× 61 0.5× 26 436
Joakim Karlsson Sweden 13 146 0.3× 176 0.4× 278 1.1× 272 1.1× 15 0.1× 24 572
Simone L. Scholz Germany 11 218 0.4× 116 0.3× 194 0.8× 154 0.6× 48 0.4× 18 444
Xuefei Zhu China 11 408 0.8× 195 0.5× 81 0.3× 272 1.1× 14 0.1× 24 747
Zahra Sadrai United States 14 203 0.4× 128 0.3× 143 0.6× 140 0.6× 409 3.6× 22 799

Countries citing papers authored by Long V. Ly

Since Specialization
Citations

This map shows the geographic impact of Long V. Ly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Long V. Ly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Long V. Ly more than expected).

Fields of papers citing papers by Long V. Ly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Long V. Ly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Long V. Ly. The network helps show where Long V. Ly may publish in the future.

Co-authorship network of co-authors of Long V. Ly

This figure shows the co-authorship network connecting the top 25 collaborators of Long V. Ly. A scholar is included among the top collaborators of Long V. Ly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Long V. Ly. Long V. Ly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ly, Long V., et al.. (2023). Subacute cutaneous lupus erythematosus after mRNA-based SARS-CoV-2 vaccination. JAAD Case Reports. 33. 70–72. 2 indexed citations
2.
Ly, Long V., et al.. (2022). A case of cutaneous Mycobacterium llatzerense. JAAD Case Reports. 31. 53–55. 2 indexed citations
3.
Ly, Long V., et al.. (2020). Incidental Skin Cancers in Debulked Rhinophymatous Tissue. Dermatologic Surgery. 47(6). 812–813. 1 indexed citations
4.
Doğrusöz, Mehmet, Niels J. Brouwer, Long V. Ly, et al.. (2020). Prognostic Factors Five Years After Enucleation for Uveal Melanoma. Investigative Ophthalmology & Visual Science. 61(3). 31–31. 22 indexed citations
5.
Ly, Long V. & Martine J. Jager. (2012). Three Generations of Eminent American Chinese. Asia-Pacific Journal of Ophthalmology. 1(3). 129–134.
6.
Ly, Long V., Gregorius P. M. Luyten, Mieke Versluis, et al.. (2012). Bevacizumab and intraocular tumors: an intriguing paradox.. PubMed. 18. 2454–67. 27 indexed citations
7.
Ly, Long V., Marjolein Sluijter, Sjoerd H. van der Burg, Martine J. Jager, & Thorbald van Hall. (2012). Effective Cooperation of Monoclonal Antibody and Peptide Vaccine for the Treatment of Mouse Melanoma. The Journal of Immunology. 190(1). 489–496. 23 indexed citations
8.
Lange, Job de, Long V. Ly, Kirsten Lodder, et al.. (2011). Synergistic growth inhibition based on small-molecule p53 activation as treatment for intraocular melanoma. Oncogene. 31(9). 1105–1116. 49 indexed citations
9.
Bronkhorst, Inge H. G., Long V. Ly, D. de Wolff–Rouendaal, et al.. (2011). Changes in immunological markers and influx of macrophages following trans‐scleral thermotherapy of uveal melanoma. Acta Ophthalmologica. 89(3). 268–273. 5 indexed citations
10.
Ly, Long V., Marjolein Sluijter, Mieke Versluis, et al.. (2010). Peptide Vaccination after T-Cell Transfer Causes Massive Clonal Expansion, Tumor Eradication, and Manageable Cytokine Storm. Cancer Research. 70(21). 8339–8346. 40 indexed citations
11.
Missotten, Guy S., Willem Maat, Long V. Ly, et al.. (2010). Regulation of VEGF-A in Uveal Melanoma. Investigative Ophthalmology & Visual Science. 51(5). 2329–2329. 60 indexed citations
12.
Ly, Long V., et al.. (2010). Intravascular Presence of Tumor Cells as Prognostic Parameter in Uveal Melanoma: A 35-Year Survey. Investigative Ophthalmology & Visual Science. 51(2). 658–658. 19 indexed citations
13.
Jager, Martine J., et al.. (2010). Macrophages in uveal melanoma and in experimental ocular tumor models: Friends or foes?. Progress in Retinal and Eye Research. 30(2). 129–146. 54 indexed citations
14.
Ly, Long V., Mieke Versluis, Ekaterina S. Jordanova, et al.. (2010). In Aged Mice, Outgrowth of Intraocular Melanoma Depends on Proangiogenic M2-Type Macrophages. The Journal of Immunology. 185(6). 3481–3488. 74 indexed citations
15.
Bronkhorst, Inge H. G., Long V. Ly, Ekaterina S. Jordanova, et al.. (2010). Detection of M2-Macrophages in Uveal Melanoma and Relation with Survival. Investigative Ophthalmology & Visual Science. 52(2). 643–643. 169 indexed citations
16.
Ly, Long V., Inge H. G. Bronkhorst, Els van Beelen, et al.. (2010). Inflammatory Cytokines in Eyes with Uveal Melanoma and Relation with Macrophage Infiltration. Investigative Ophthalmology & Visual Science. 51(11). 5445–5445. 44 indexed citations
17.
Piña, Yolanda, Timothy G. Murray, Martine J. Jager, et al.. (2010). Impact of Tumor-Associated Macrophages in LHBETATAGMice on Retinal Tumor Progression: Relation to Macrophage Subtype. Investigative Ophthalmology & Visual Science. 51(5). 2671–2671. 19 indexed citations
18.
Maat, Willem, Arno R. van der Slik, Behrooz Z. Alizadeh, et al.. (2009). Evidence for Natural Killer Cell–Mediated Protection from Metastasis Formation in Uveal Melanoma Patients. Investigative Ophthalmology & Visual Science. 50(6). 2888–2888. 27 indexed citations
19.
Maat, Willem, Long V. Ly, Ekaterina S. Jordanova, et al.. (2008). Monosomy of Chromosome 3 and an Inflammatory Phenotype Occur Together in Uveal Melanoma. Investigative Ophthalmology & Visual Science. 49(2). 505–505. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Inge H. G. Bronkhorst Breakdown of academic impact, for papers by Mieke Versluis Breakdown of academic impact, for papers by Willem Maat Breakdown of academic impact, for papers by Junna Oba Breakdown of academic impact, for papers by Mallikarjuna Kandalam Breakdown of academic impact, for papers by Sebastian Di Cesare Breakdown of academic impact, for papers by Joakim Karlsson Breakdown of academic impact, for papers by Simone L. Scholz Breakdown of academic impact, for papers by Xuefei Zhu Breakdown of academic impact, for papers by Zahra Sadrai
Rankless by CCL
2026